{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T01:15:19Z","timestamp":1787966119861,"version":"build-2784847793"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s10147-026-03074-3","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T11:41:10Z","timestamp":1781005270000},"page":"1645-1657","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Geriatric nutritional risk index for the prediction of venous thrombotic events in multiple myeloma"],"prefix":"10.1007","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0300-378X","authenticated-orcid":false,"given":"Kazuhito","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadahiro","family":"Gunji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riku","family":"Nagao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaharu","family":"Kawashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Uryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamiko","family":"Momoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroto","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoko","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuji","family":"Katori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Katsube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaichi","family":"Nishiwaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Yano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"key":"3074_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/s41375-021-01453-5","volume":"36","author":"M Binder","year":"2022","unstructured":"Binder M, Nandakumar B, Rajkumar SV et al (2022) Mortality trends in multiple myeloma after the introduction of novel therapies in the United States. Leukemia 36:801\u2013808. https:\/\/doi.org\/10.1038\/s41375-021-01453-5","journal-title":"Leukemia"},{"key":"3074_CR2","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1182\/blood-2014-12-615187","volume":"125","author":"A Palumbo","year":"2025","unstructured":"Palumbo A, Bringhen S, Mateos MV et al (2025) Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an international myeloma working group report. Blood 125:2068\u20132074. https:\/\/doi.org\/10.1182\/blood-2014-12-615187","journal-title":"Blood"},{"key":"3074_CR3","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1093\/ajcn\/82.4.777","volume":"82","author":"O Bouillanne","year":"2005","unstructured":"Bouillanne O, Morineau G, Dupont C et al (2005) Geriatric nutritional risk index: a new index for evaluating at-risk elderly medical patients. Am J Clin Nutr 82:777\u2013783. https:\/\/doi.org\/10.1093\/ajcn\/82.4.777","journal-title":"Am J Clin Nutr"},{"key":"3074_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2023.1274592","volume":"10","author":"Q Yu","year":"2023","unstructured":"Yu Q, Tian M, Pi G et al (2023) Geriatric nutritional risk index as a predictor of prognosis in hematologic malignancies: a systematic review and meta-analysis. Front Nutr 10:1274592. https:\/\/doi.org\/10.3389\/fnut.2023.1274592","journal-title":"Front Nutr"},{"key":"3074_CR5","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1002\/hon.2760","volume":"38","author":"Y Nishiyama-Fujita","year":"2020","unstructured":"Nishiyama-Fujita Y, Nakazato T, Kamiya T et al (2020) The geriatric nutritional risk index predicts the early death and survival in patients with myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia-related changes treated with azacitidine. Hematol Oncol 38:611\u2013613. https:\/\/doi.org\/10.1002\/hon.2760","journal-title":"Hematol Oncol"},{"key":"3074_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.nutos.2025.12.003","volume":"65","author":"K Suzuki","year":"2026","unstructured":"Suzuki K, Gunji T, Nagao R et al (2026) Geriatric nutritional risk index in multiple myeloma. Clin Nutr Open Sci 65:100609. https:\/\/doi.org\/10.1016\/j.nutos.2025.12.003","journal-title":"Clin Nutr Open Sci"},{"key":"3074_CR7","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1111\/j.1538-7836.2007.02374.x","volume":"5","author":"AA Khorana","year":"2007","unstructured":"Khorana AA, Francis CW, Culakova E et al (2007) Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost 5:632\u2013634. https:\/\/doi.org\/10.1111\/j.1538-7836.2007.02374.x","journal-title":"J Thromb Haemost"},{"key":"3074_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-015-0592-8","volume":"13","author":"J Khalil","year":"2015","unstructured":"Khalil J, Bensaid B, Elkacemi H et al (2015) Venous thromboembolism in cancer patients: an underestimated major health problem. World J Surg Oncol 13:204. https:\/\/doi.org\/10.1186\/s12957-015-0592-8","journal-title":"World J Surg Oncol"},{"key":"3074_CR9","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1182\/asheducation-2010.1.437","volume":"2010","author":"SY Kristinsson","year":"2010","unstructured":"Kristinsson SY (2010) Thrombosis in multiple myeloma. Hematol Am Soc Hematol Educ Progr 2010:437\u2013444","journal-title":"Hematol Am Soc Hematol Educ Progr"},{"key":"3074_CR10","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1182\/blood.2020009980","volume":"137","author":"FI Mulder","year":"2021","unstructured":"Mulder FI, Horv\u00e1th-Puh\u00f3 E, van Es N et al (2021) Venous thromboembolism in cancer patients: a population-based cohort study. Blood 137:1959\u20131969. https:\/\/doi.org\/10.1182\/blood.2020009980","journal-title":"Blood"},{"key":"3074_CR11","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.3324\/haematol.2012.062041","volume":"97","author":"SY Kristinsson","year":"2012","unstructured":"Kristinsson SY, Pfeiffer RM, Bj\u00f6rkholm M et al (2012) Thrombosis is associated with inferior survival in multiple myeloma. Haematologica 97:1603\u20131607. https:\/\/doi.org\/10.3324\/haematol.2012.062041","journal-title":"Haematologica"},{"key":"3074_CR12","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1002\/rth2.12429","volume":"4","author":"MW Schoen","year":"2020","unstructured":"Schoen MW, Carson KR, Luo S et al (2020) Venous thromboembolism in multiple myeloma is associated with increased mortality. Res Pract Thromb Haemost 4:1203\u20131210. https:\/\/doi.org\/10.1002\/rth2.12429","journal-title":"Res Pract Thromb Haemost"},{"key":"3074_CR13","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/sj.leu.2405030","volume":"22","author":"A Palumbo","year":"2008","unstructured":"Palumbo A, Rajkumar SV, Dimopoulos MA et al (2008) Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma. Leukemia 22:414\u2013423. https:\/\/doi.org\/10.1038\/sj.leu.2405030","journal-title":"Leukemia"},{"key":"3074_CR14","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1200\/JCO.2013.51.2267","volume":"32","author":"A Palumbo","year":"2014","unstructured":"Palumbo A, Rajkumar SV, San Miguel JF et al (2014) International myeloma working group consensus statement for management, treatment, and supportive care of patients with myeloma not eligible for standard autologous stem-cell transplantation. J Clin Oncol 32:587\u2013600. https:\/\/doi.org\/10.1200\/JCO.2013.51.2267","journal-title":"J Clin Oncol"},{"key":"3074_CR15","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1111\/j.1538-7836.2011.04258.x","volume":"9","author":"M Carrier","year":"2011","unstructured":"Carrier M, Le Gal G, Tay J et al (2011) Rates of venous thromboembolism in multiple myeloma patients undergoing immunomodulatory therapy\u2014a systematic review and meta-analysis. J Thromb Haemost 9:653\u2013663. https:\/\/doi.org\/10.1111\/j.1538-7836.2011.04258.x","journal-title":"J Thromb Haemost"},{"key":"3074_CR16","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12959-023-00512-1","volume":"21","author":"X Li","year":"2023","unstructured":"Li X, Sun X, Fang B et al (2023) Development and validation of a new risk assessment model for immunomodulatory drug-associated venous thrombosis among Chinese multiple myeloma patients. Thromb Res 21:105. https:\/\/doi.org\/10.1186\/s12959-023-00512-1","journal-title":"Thromb Res"},{"key":"3074_CR17","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1093\/gerona\/62.1.79","volume":"62","author":"AR Folsom","year":"2007","unstructured":"Folsom AR, Boland LL, Cushman M et al (2007) Frailty and risk of venous thromboembolism in older adults. J Gerontol A Biol Sci Med Sci 62:79\u201382. https:\/\/doi.org\/10.1093\/gerona\/62.1.79","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"3074_CR18","doi-asserted-by":"publisher","first-page":"afab211","DOI":"10.1093\/ageing\/afab211","volume":"51","author":"Y Yao","year":"2022","unstructured":"Yao Y, Sui WW, Liao AJ et al (2022) Comprehensive geriatric assessment in newly diagnosed older myeloma patients: a prospective non-interventional multicentre study. Age Ageing 51:afab211. https:\/\/doi.org\/10.1093\/ageing\/afab211","journal-title":"Age Ageing"},{"key":"3074_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-10-50","volume":"10","author":"O Arrieta","year":"2010","unstructured":"Arrieta O, Michel Ortega RM, Villanueva-Rodr\u00edguez G (2010) Association of nutritional status and serum albumin with development of toxicity in advanced NSCLC patients treated with paclitaxel-cisplatin. BMC Cancer 10:50. https:\/\/doi.org\/10.1186\/1471-2407-10-50","journal-title":"BMC Cancer"},{"key":"3074_CR20","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1093\/annonc\/mdu326","volume":"25","author":"KS Versteeg","year":"2014","unstructured":"Versteeg KS, Konings IR, Lagaay AM et al (2014) Prediction of treatment-related toxicity and outcome with geriatric assessment in elderly patients with solid malignancies treated with chemotherapy: a systematic review. Ann Oncol 25:1914\u20131918. https:\/\/doi.org\/10.1093\/annonc\/mdu326","journal-title":"Ann Oncol"},{"key":"3074_CR21","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1080\/01635581.2021.1952631","volume":"74","author":"M Sari","year":"2022","unstructured":"Sari M, Ilhan Y, Sezgin Goksu S et al (2022) The relationship between nutritional parameters and thrombosis risk in cancer patients. Nutr Cancer 74:1370\u20131375. https:\/\/doi.org\/10.1080\/01635581.2021.1952631","journal-title":"Nutr Cancer"},{"key":"3074_CR22","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","volume":"15","author":"SV Rajkumar","year":"2014","unstructured":"Rajkumar SV, Dimopoulos MA, Palumbo A et al (2014) International myeloma working group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol 15:e538\u2013e548. https:\/\/doi.org\/10.1016\/S1470-2045(14)70442-5","journal-title":"Lancet Oncol"},{"key":"3074_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/rth2.12634","volume":"6","author":"KM Sanfilippo","year":"2022","unstructured":"Sanfilippo KM, Carson KR, Wang TF et al (2022) Evaluation of the Khorana score for prediction of venous thromboembolism in patients with multiple myeloma. Res Pract Thromb Haemost 6:e12634. https:\/\/doi.org\/10.1002\/rth2.12634","journal-title":"Res Pract Thromb Haemost"},{"key":"3074_CR24","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1002\/ajh.25522","volume":"94","author":"KM Sanfilippo","year":"2019","unstructured":"Sanfilippo KM, Luo S, Wang TF et al (2019) Predicting venous thromboembolism in multiple myeloma: development and validation of the IMPEDE-VTE score. Am J Hematol 94:1176\u20131184. https:\/\/doi.org\/10.1002\/ajh.25522","journal-title":"Am J Hematol"},{"key":"3074_CR25","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1182\/blood.2022016396","volume":"140","author":"R Chakraborty","year":"2022","unstructured":"Chakraborty R, Rybicki L, Wei W et al (2022) Abnormal metaphase cytogenetics predicts venous thromboembolism in myeloma: derivation and validation of the PRISM score. Blood 140:2443\u20132450. https:\/\/doi.org\/10.1182\/blood.2022016396","journal-title":"Blood"},{"key":"3074_CR26","doi-asserted-by":"publisher","first-page":"840","DOI":"10.6004\/jnccn.2019.7300","volume":"17","author":"A Li","year":"2019","unstructured":"Li A, Wu Q, Luo S et al (2019) Derivation and validation of a risk assessment model for immunomodulatory drug\u2013associated thrombosis among patients with multiple myeloma. J Natl Compr Canc Netw 17:840\u2013847. https:\/\/doi.org\/10.6004\/jnccn.2019.7300","journal-title":"J Natl Compr Canc Netw"},{"key":"3074_CR27","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","volume":"121","author":"International Myeloma Working Group","year":"2003","unstructured":"International Myeloma Working Group (2003) Criteria for classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol 121:749\u2013757. https:\/\/doi.org\/10.1046\/j.1365-2141.2003.04355.x","journal-title":"Br J Haematol"},{"key":"3074_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clnu.2018.08.002","volume":"38","author":"T Cederholm","year":"2019","unstructured":"Cederholm T, Jensen GL, Correia MITD et al (2019) GLIM criteria for the diagnosis of malnutrition: a consensus report from the global clinical nutrition community. Clin Nutr 38:1\u20139. https:\/\/doi.org\/10.1016\/j.clnu.2018.08.002","journal-title":"Clin Nutr"},{"key":"3074_CR29","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41375-019-0630-8","volume":"34","author":"T Facon","year":"2020","unstructured":"Facon T, Dimopoulos MA, Meuleman N et al (2020) A simplified frailty scale predicts outcomes in transplant-ineligible newly diagnosed multiple myeloma patients treated in the FIRST (MM-020) trial. Leukemia 34:224\u2013233. https:\/\/doi.org\/10.1038\/s41375-019-0630-8","journal-title":"Leukemia"},{"key":"3074_CR30","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1182\/blood-2016-01-696776","volume":"127","author":"P Sonneveld","year":"2016","unstructured":"Sonneveld P, Avet-Loiseau H, Lonial S et al (2016) Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working Group. Blood 127:2955\u20132962. https:\/\/doi.org\/10.1182\/blood-2016-01-696776","journal-title":"Blood"},{"key":"3074_CR31","doi-asserted-by":"publisher","first-page":"e328","DOI":"10.1016\/S1470-2045(16)30206-6","volume":"17","author":"S Kumar","year":"2016","unstructured":"Kumar S, Paiva B, Anderson KC et al (2016) IMWG consensus criteria for response and minimal residual disease assessment in multiple myeloma. Lancet Oncol 17:e328\u2013e346. https:\/\/doi.org\/10.1016\/S1470-2045(16)30206-6","journal-title":"Lancet Oncol"},{"key":"3074_CR32","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y (2013) Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics. Bone Marrow Transplant 48:452\u2013458. https:\/\/doi.org\/10.1038\/bmt.2012.244","journal-title":"Bone Marrow Transplant"},{"key":"3074_CR33","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.21873\/anticanres.14216","volume":"40","author":"T Iguchi","year":"2020","unstructured":"Iguchi T, Sugimachi K, Mano Y et al (2020) The preoperative prognostic nutritional index predicts development of deep venous thrombosis after pancreatic surgery. Anticancer Res 40:2297\u20132301. https:\/\/doi.org\/10.21873\/anticanres.14216","journal-title":"Anticancer Res"},{"key":"3074_CR34","doi-asserted-by":"publisher","first-page":"85","DOI":"10.4103\/2229-5151.183024","volume":"6","author":"HF Al-Azzawi","year":"2016","unstructured":"Al-Azzawi HF, Obi OC, Safi J et al (2016) Nephrotic syndrome-induced thromboembolism in adults. Int J Crit Illn Inj Sci 6:85\u201388. https:\/\/doi.org\/10.4103\/2229-5151.183024","journal-title":"Int J Crit Illn Inj Sci"},{"key":"3074_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2023.114237","volume":"209","author":"JM Bauer","year":"2024","unstructured":"Bauer JM, Pattwell M, Barazzoni R et al (2024) Systematic nutritional screening and assessment in older patients: rationale for integration into oncology practice. Eur J Cancer 209:114237. https:\/\/doi.org\/10.1016\/j.ejca.2023.114237","journal-title":"Eur J Cancer"},{"key":"3074_CR36","doi-asserted-by":"publisher","first-page":"355","DOI":"10.4236\/ojo.2024.148024","volume":"14","author":"T Kaneko","year":"2024","unstructured":"Kaneko T, Hayakawa K, Miyazaki T (2024) Malnutrition assessed using geriatric nutritional risk index is associated with preoperative incidence of deep vein thrombosis in Japanese patients undergoing total knee arthroplasty. Open J Orthop 14:355\u2013365. https:\/\/doi.org\/10.4236\/ojo.2024.148024","journal-title":"Open J Orthop"},{"key":"3074_CR37","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/bjs.4425","volume":"91","author":"BL Cheuk","year":"2004","unstructured":"Cheuk BL, Cheung GC, Cheng SW (2004) Epidemiology of venous thromboembolism in a Chinese population. Br J Surg 91:424\u2013428. https:\/\/doi.org\/10.1002\/bjs.4425","journal-title":"Br J Surg"},{"key":"3074_CR38","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1016\/S0002-9149(00)00754-6","volume":"85","author":"AL Klatsky","year":"2000","unstructured":"Klatsky AL, Armstrong MA, Poggi J (2000) Risk of pulmonary embolism and\/or deep venous thrombosis in Asian\u2013Americans. Am J Cardiol 85:1334\u20131337. https:\/\/doi.org\/10.1016\/S0002-9149(00)00754-6","journal-title":"Am J Cardiol"},{"key":"3074_CR39","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1160\/TH04-06-0402","volume":"93","author":"RH White","year":"2005","unstructured":"White RH, Zhou H, Murin S et al (2005) Effect of ethnicity and gender on incidence of venous thromboembolism in a diverse California population in 1996. Thromb Haemost 93:298\u2013305. https:\/\/doi.org\/10.1160\/TH04-06-0402","journal-title":"Thromb Haemost"},{"key":"3074_CR40","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/ajh.26713","volume":"98","author":"C Charalampous","year":"2023","unstructured":"Charalampous C, Goel U, Kapoor P et al (2023) Thrombosis in multiple myeloma: risk estimation by induction regimen and association with overall survival. Am J Hematol 98:413\u2013420. https:\/\/doi.org\/10.1002\/ajh.26713","journal-title":"Am J Hematol"},{"key":"3074_CR41","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1046\/j.1525-139X.2004.17085.x","volume":"17","author":"BR Don","year":"2004","unstructured":"Don BR, Kaysen G (2004) Serum albumin: relationship to inflammation and nutrition. Semin Dial 17:432\u2013437. https:\/\/doi.org\/10.1046\/j.1525-139X.2004.17085.x","journal-title":"Semin Dial"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-026-03074-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-026-03074-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-026-03074-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T16:35:48Z","timestamp":1784997348000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-026-03074-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["3074"],"URL":"https:\/\/doi.org\/10.1007\/s10147-026-03074-3","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,9]]},"assertion":[{"value":"11 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K. Suzuki received personal fees from Janssen Pharmaceutical K.K., Sanofi, Bristol Myers Squibb, GSK, Ono Pharmaceutical Co., Ltd, Pfizer, and Takeda Pharmaceutical Company outside the submitted work; R. Nagao received personal fees from Janssen Pharmaceutical K.K. and Sanofi outside the submitted work; K. Nishiwaki reports personal fees from Kyowa Hakko Kirin Co, Ltd, outside the submitted work; S. Yano reports grants from Kyowa Kirin, Astella Pharma, Chugai Pharma, Mochida Pharma, Lilly Pharma, Takeda Pharma, MDS Pharma, Pfizer, Dai Nippon Sumitomo Pharma, and Ono Pharma outside the submitted work. The authors declare no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}